NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
June 20, 2024 — RCSI Medical University of Bahrain announces a USD 45 million campus expansion project to improve healthcare and education, with significant economic and sustainability impact.
June 20, 2024 — Discover how <b>Prenetics Global Limited (NASDAQ: PRE) </b> is making waves in cancer care with its genomics-driven health sciences technology. Learn about the company's strong financial performance, promising clinical trials, and strategic focus on the US market.
June 20, 2024 — NOVA recognizes Dr. Gray and Dr. Chapman for their outstanding efforts in advancing victims' rights. The doctors advocate for increased funding and support for victim services organizations, highlighting the critical need for sustained resources to assist victims of violent crimes.
June 18, 2024 — Dr. Stacey Bone, veterinarian and senior pet advocate, discusses the importance of proper nutrition and care for senior pets, along with the benefits of considering senior pet adoption from shelters.
June 18, 2024 — Clene (NASDAQ: CLNN) CEO and CFO provide corporate updates and future plans at Emerging Growth Conference, highlighting progress in developing treatments for ALS and MS.
June 18, 2024 — Learn about Safety Shot's groundbreaking beverage for alcohol effects alleviation, its potential to treat alcohol poisoning, and its nationwide availability. Discover the impact of Safety Shot on public health and the growing market for hangover cure products.
June 17, 2024 — Learn about KC White's personal journey and the progress in care and treatment options for cystic fibrosis. The Cystic Fibrosis Foundation is committed to finding a cure and providing all people with CF the opportunity to lead long, fulfilling lives.
June 17, 2024 — Cardiol Therapeutics reports positive topline results from Phase II MAvERIC-Pilot study, demonstrating potential breakthrough in recurrent pericarditis treatment.
June 14, 2024 — Lisata Therapeutics CEO discusses completion of patient enrollment for pancreatic cancer trial in Phase 1B/2A CENDIFOX trial
June 14, 2024 — Candel Therapeutics, Inc. leverages enLIGHTEN Discovery Platform for next-gen viral immunotherapy, presenting promising preclinical data at key industry conferences. Collaborations with University of Pennsylvania also in progress.
June 13, 2024 — Discover how AI chatbots like Muah AI are revolutionizing emotional support. Learn about the impact of advanced machine learning algorithms on addressing the loneliness epidemic in the United States.
June 13, 2024 — Mainz Biomed's ColoAlert offers a revolutionary approach to colorectal cancer testing, with the potential to increase early detection rates and save lives. Learn how this innovative product could impact the future of cancer screening and prevention.
June 13, 2024 — Learn how Autonomix's groundbreaking technology may transform pancreatic cancer pain relief. First in-human pilot study underway with preliminary results set to be released on June 18, 2024.
June 13, 2024 — Discover the latest advancements in skincare tightening and rejuvenation with Morpheus8 Skin Remodelling offered by Kitsilano Medical Aesthetics. Expertly tailored treatments by Dr. Roz Kamani provide lasting results for a non-surgical solution to combat the signs of aging.
June 12, 2024 — Clene Inc., a clinical-stage biopharmaceutical company, is set to present at the 72nd Emerging Growth Conference, featuring its investigational therapy for neurodegenerative diseases. Learn more about the company's participation and potential breakthroughs.
June 12, 2024 — Dr. Ashley Ibbotson, PhD, has joined Mid Cities Psychiatry, bolstering their mental health services with compassionate care and a wide range of therapy options for individuals of all ages.
June 11, 2024 — Tonix Pharmaceuticals CEO Dr. Seth Lederman announces the completion of the initial phase of an assessment on the U.S. market opportunity for Tonmya, a potential groundbreaking first-line therapy for fibromyalgia management.
June 10, 2024 — Dr. Mark McFarland performs groundbreaking outpatient procedures for vertebrogenic back pain, offering hope to patients suffering from chronic low back pain. The innovative procedure signifies a step forward in spinal treatments, providing a safer and durable alternative for those seeking relief.
June 10, 2024 — Elicio Therapeutics announces promising phase 1a data for ELI-002 7P in mKRAS tumors, offering hope to patients with aggressive cancers. The innovative approach and encouraging early results signify a significant advancement in cancer treatment.
June 7, 2024 — Theriva Biologics receives FDA Fast Track Designation for VCN-01, a promising treatment for pancreatic cancer. This milestone underscores the potential to improve patient outcomes and reduce mortality. Learn more about the company's innovative approach to cancer treatment.